HCPCS 'M' Codes (204)

Medical Services
Code Description
M0001 Advancing cancer care mips value pathways
M0002 Optimal care for kidney health mips value pathways
M0003 Optimal care for patients with episodic neurological conditions mips value pathways
M0004 Supportive care for neurodegenerative conditions mips value pathways
M0005 Promoting wellness mips value pathways
M0064 Brief office visit for the sole purpose of monitoring or changing drug prescriptions used in the treatment of mental psychoneurotic and personality disorders
Terminated December 31, 2014.
M0075 Cellular therapy
M0076 Prolotherapy
M0100 Intragastric hypothermia using gastric freezing
M0201 Covid-19 vaccine administration inside a patient's home; reported only once per individual home per date of service when only covid-19 vaccine administration is performed at the patient's home
M0220 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring
M0221 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring
M0223 Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring
Terminated April 16, 2021.
M0240 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses
M0241 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring
M0244 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring
M0246 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider based to the hospital during the covid 19 public health emergency
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring
M0248 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
M0249 Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose
M0250 Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose
M0300 Iv chelation therapy (chemical endarterectomy)
M0301 Fabric wrapping of abdominal aneurysm
M1000 Pain screened as moderate to severe
Terminated December 31, 2019.
M1001 Plan of care to address moderate to severe pain documented on or before the date of the second visit with a clinician
Terminated December 31, 2019.
M1002 Plan of care for moderate to severe pain not documented on or before the date of the second visit with a clinician, reason not given
Terminated December 31, 2019.
M1003 Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy
M1004 Documentation of medical reason for not screening for tb or interpreting results (i.e., patient positive for tb and documentation of past treatment; patient who has recently completed a course of anti-tb therapy)
M1005 Tb screening not performed or results not interpreted, reason not given
M1006 Disease activity not assessed, reason not given
M1007 >=50% of total number of a patient's outpatient ra encounters assessed
M1008 <50% of total number of a patient's outpatient ra encounters assessed
M1009 Discharge/discontinuation of the episode of care documented in the medical record
M1010 Discharge/discontinuation of the episode of care documented in the medical record
M1011 Discharge/discontinuation of the episode of care documented in the medical record
M1012 Discharge/discontinuation of the episode of care documented in the medical record
M1013 Discharge/discontinuation of the episode of care documented in the medical record
M1014 Discharge/discontinuation of the episode of care documented in the medical record
M1015 Discharge/discontinuation of the episode of care documented in the medical record
Terminated December 31, 2020.
M1016 Female patients unable to bear children
M1017 Patient admitted to palliative care services
Terminated December 31, 2022.
M1018 Patients with an active diagnosis or history of cancer (except basal cell and squamous cell skin carcinoma), patients who are heavy tobacco smokers, lung cancer screening patients
M1019 Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5
M1020 Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq-9 or phq-9m score was not assessed or is greater than or equal to 5
M1021 Patient had only urgent care visits during the performance period
M1022 Patients who were in hospice at any time during the performance period
Terminated December 31, 2021.
M1023 Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five
Terminated December 31, 2020.
M1024 Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five. either phq-9 or phq-9m score was not assessed or is greater than or equal to five
Terminated December 31, 2020.
M1025 Patients who were in hospice at any time during the performance period
Terminated December 31, 2021.
M1026 Patients who were in hospice at any time during the performance period
Terminated December 31, 2021.
M1027 Imaging of the head (ct or mri) was obtained
M1028 Documentation of patients with primary headache diagnosis and imaging other than ct or mri obtained
M1029 Imaging of the head (ct or mri) was not obtained, reason not given
M1030 Patients with clinical indications for imaging of the head
Terminated December 31, 2019.
M1031 Patients with no clinical indications for imaging of the head
Terminated December 31, 2021.
M1032 Adults currently taking pharmacotherapy for oud
M1033 Pharmacotherapy for oud initiated after june 30th of performance period
Terminated December 31, 2020.
M1034 Adults who have at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days
M1035 Adults who are deliberately phased out of medication assisted treatment (mat) prior to 180 days of continuous treatment
M1036 Adults who have not had at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days
M1037 Patients with a diagnosis of lumbar spine region cancer at the time of the procedure
M1038 Patients with a diagnosis of lumbar spine region fracture at the time of the procedure
M1039 Patients with a diagnosis of lumbar spine region infection at the time of the procedure
M1040 Patients with a diagnosis of lumbar idiopathic or congenital scoliosis
M1041 Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular, idiopathic or congenital lumbar scoliosis
M1042 Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively
Terminated December 31, 2019.
M1043 Functional status was not measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively
M1044 Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively
Terminated December 31, 2019.
M1045 Functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was greater than or equal to 37 or knee injury and osteoarthritis outcome score joint replacement (koos, jr.) was greater than or equal to 71
M1046 Functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was less than 37 or the knee injury and osteoarthritis outcome score joint replacement (koos, jr.) was less than 71 postoperatively
M1047 Functional status was measured by the oxford knee score (oks) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively
Terminated December 31, 2019.
M1048 Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively
Terminated December 31, 2019.
M1049 Functional status was not measured by the oswestry disability index (odi version 2.1a) at three months (6 - 20 weeks) postoperatively
M1050 Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively
Terminated December 31, 2019.
M1051 Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular, idiopathic or congenital lumbar scoliosis
M1052 Leg pain was not measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively
M1053 Leg pain was measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively
Terminated December 31, 2019.
M1054 Patient had only urgent care visits during the performance period
M1055 Aspirin or another antiplatelet therapy used
M1056 Prescribed anticoagulant medication during the performance period, history of gi bleeding, history of intracranial bleeding, bleeding disorder and specific provider documented reasons: allergy to aspirin or anti-platelets, use of non-steroidal anti-inflammatory agents, drug-drug interaction, uncontrolled hypertension > 180/110 mmhg or gastroesophageal reflux disease
M1057 Aspirin or another antiplatelet therapy not used, reason not given
M1058 Patient was a permanent nursing home resident at any time during the performance period
M1059 Patient was in hospice or receiving palliative care at any time during the performance period
M1060 Patient died prior to the end of the performance period
M1061 Patient pregnancy
Terminated December 31, 2020.
M1062 Patient immunocompromised
Terminated December 31, 2020.
M1063 Patients receiving high doses of immunosuppressive therapy
Terminated December 31, 2020.
M1064 Shingrix vaccine documented as administered or previously received
Terminated December 31, 2020.
M1065 Shingrix vaccine was not administered for reasons documented by clinician (e.g. patient administered vaccine other than shingrix, patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)
Terminated December 31, 2020.
M1066 Shingrix vaccine not documented as administered, reason not given
Terminated December 31, 2020.
M1067 Hospice services for patient provided any time during the measurement period
M1068 Adults who are not ambulatory
M1069 Patient screened for future fall risk
M1070 Patient not screened for future fall risk, reason not given
M1071 Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminotomy
Terminated December 31, 2022.
M1106 The start of an episode of care documented in the medical record
M1107 Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
M1108 Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
M1109 Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
M1110 Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1111 The start of an episode of care documented in the medical record
M1112 Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
M1113 Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
M1114 Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
M1115 Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1116 The start of an episode of care documented in the medical record
M1117 Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
M1118 Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
M1119 Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
M1120 Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1121 The start of an episode of care documented in the medical record
M1122 Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
M1123 Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
M1124 Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
M1125 Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1126 The start of an episode of care documented in the medical record
M1127 Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
M1128 Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
M1129 Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
M1130 Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1131 Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
M1132 Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
M1133 Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
M1134 Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1135 The start of an episode of care documented in the medical record
M1136 The start of an episode of care documented in the medical record
Terminated December 31, 2020.
M1137 Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
Terminated December 31, 2020.
M1138 Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only)
Terminated December 31, 2020.
M1139 Ongoing care not indicated, patient self-discharged early and seen only 1-2 visits (e.g., financial or insurance reasons, transportation problems, or reason unknown)
Terminated December 31, 2020.
M1140 Ongoing care not indicated, patient discharged after only 1-2 visits due to specific medical events, documented in the medical record that make the treatment episode impossible such as the patient becomes hospitalized or scheduled for surgery for surgery or hospitalized
Terminated December 31, 2020.
M1141 Functional status was not measured by the oxford knee score (oks) or the knee injury and osteoarthritis outcome score joint replacement (koos, jr.) at one year (9 to 15 months) postoperatively
M1142 Emergent cases
M1143 Initiated episode of rehabilitation therapy, medical, or chiropractic care for neck impairment
M1144 Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only
Terminated December 31, 2020.
M1145 Most favored nation (mfn) model drug add-on amount, per dose, (do not bill with line items that have the jw modifier)
Terminated February 27, 2022.
M1146 Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
M1147 Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
M1148 Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1149 Patient unable to complete the neck fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility, and an adequate proxy is not available
M1150 Left ventricular ejection fraction (lvef) less than or equal to 40% or documentation of moderately or severely depressed left ventricular systolic function
M1151 Patients with a history of heart transplant or with a left ventricular assist device (lvad)
M1152 Patients with a history of heart transplant or with a left ventricular assist device (lvad)
M1153 Patient with diagnosis of osteoporosis on date of encounter
M1154 Hospice services provided to patient any time during the measurement period
M1155 Patient had anaphylaxis due to the pneumococcal vaccine any time during or before the measurement period
M1156 Patient received active chemotherapy any time during the measurement period
M1157 Patient received bone marrow transplant any time during the measurement period
M1158 Patient had history of immunocompromising conditions prior to or during the measurement period
M1159 Hospice services provided to patient any time during the measurement period
M1160 Patient had anaphylaxis due to the meningococcal vaccine any time on or before the patient's 13th birthday
M1161 Patient had anaphylaxis due to the tetanus, diphtheria or pertussis vaccine any time on or before the patient's 13th birthday
M1162 Patient had encephalitis due to the tetanus, diphtheria or pertussis vaccine any time on or before the patient's 13th birthday
M1163 Patient had anaphylaxis due to the hpv vaccine any time on or before the patient's 13th birthday
M1164 Patients with dementia any time during the patient's history through the end of the measurement period
M1165 Patients who use hospice services any time during the measurement period
M1166 Pathology report for tissue specimens produced from wide local excisions or re-excisions
M1167 In hospice or using hospice services during the measurement period
M1168 Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period
M1169 Documentation of medical reason(s) for not administering influenza vaccine (e.g., prior anaphylaxis due to the influenza vaccine)
M1170 Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period
M1171 Patient received at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period
M1172 Documentation of medical reason(s) for not administering td or tdap vaccine (e.g., prior anaphylaxis due to the td or tdap vaccine or history of encephalopathy within seven days after a previous dose of a td-containing vaccine)
M1173 Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period
M1174 Patient received at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period
M1175 Documentation of medical reason(s) for not administering zoster vaccine (e.g., prior anaphylaxis due to the zoster vaccine)
M1176 Patient did not receive at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period
M1177 Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 60th birthday and before the end of the measurement period
M1178 Documentation of medical reason(s) for not administering pneumococcal vaccine (e.g., prior anaphylaxis due to the pneumococcal vaccine)
M1179 Patient did not receive any pneumococcal conjugate or polysaccharide vaccine, on or after their 60th birthday and before or during measurement period
M1180 Patients on immune checkpoint inhibitor therapy
M1181 Grade 2 or above diarrhea and/or grade 2 or above colitis
M1182 Patients not eligible due to pre-existing inflammatory bowel disease (ibd) (e.g., ulcerative colitis, crohn's disease)
M1183 Documentation of immune checkpoint inhibitor therapy held and corticosteroids or immunosuppressants prescribed or administered
M1184 Documentation of medical reason(s) for not prescribing or administering corticosteroid or immunosuppressant treatment (e.g., allergy, intolerance, infectious etiology, pancreatic insufficiency, hyperthyroidism, prior bowel surgical interventions, celiac disease, receiving other medication, awaiting diagnostic workup results for alternative etiologies, other medical reasons/contraindication)
M1185 Documentation of immune checkpoint inhibitor therapy not held and/or corticosteroids or immunosuppressants prescribed or administered was not performed, reason not given
M1186 Patients who have an order for or are receiving hospice or palliative care
M1187 Patients with a diagnosis of end stage renal disease (esrd)
M1188 Patients with a diagnosis of chronic kidney disease (ckd) stage 5
M1189 Documentation of a kidney health evaluation defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr) performed
M1190 Documentation of a kidney health evaluation was not performed or defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr)
M1191 Hospice services provided to patient any time during the measurement period
M1192 Patients with an existing diagnosis of squamous cell carcinoma of the esophagus
M1193 Surgical pathology reports that contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both
M1194 Documentation of medical reason(s) surgical pathology reports did not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both tests were not included (e.g., patient will not be treated with checkpoint inhibitor therapy, no residual carcinoma is present in the sample [tissue exhausted or status post neoadjuvant treatment], insufficient tumor for testing)
M1195 Surgical pathology reports that do not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both, reason not given
M1196 Initial (index visit) numeric rating scale (nrs), visual rating scale (vrs), or itchyquant assessment score of greater than or equal to 4
M1197 Itch severity assessment score is reduced by 2 or more points from the initial (index) assessment score to the follow-up visit score
M1198 Itch severity assessment score was not reduced by at least 2 points from initial (index) score to the follow-up visit score or assessment was not completed during the follow-up encounter
M1199 Patients receiving rrt
M1200 Ace inhibitor (ace-i) or arb therapy prescribed during the measurement period
M1201 Documentation of medical reason(s) for not prescribing ace inhibitor (ace-i) or arb therapy during the measurement period (e.g., pregnancy, history of angioedema to ace-i, other allergy to ace-i and arb, hyperkalemia or history of hyperkalemia while on ace-i or arb therapy, acute kidney injury due to ace-i or arb therapy), other medical reasons)
M1202 Documentation of patient reason(s) for not prescribing ace inhibitor or arb therapy during the measurement period, (e.g., patient declined, other patient reasons)
M1203 Ace inhibitor or arb therapy not prescribed during the measurement period, reason not given
M1204 Initial (index visit) numeric rating scale (nrs), visual rating scale (vrs), or itchyquant assessment score of greater than or equal to 4
M1205 Itch severity assessment score is reduced by 2 or more points from the initial (index) assessment score to the follow-up visit score
M1206 Itch severity assessment score was not reduced by at least 2 points from initial (index) score to the follow-up visit score or assessment was not completed during the follow-up encounter
M1207 Number of patients screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety
M1208 Number of patients not screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety
M1209 At least two orders for high-risk medications from the same drug class, (table 4), not ordered
M1210 At least two orders for high-risk medications from the same drug class, (table 4), not ordered